Arcturus Therapeutics Files 8-K on Shareholder Votes
Ticker: ARCT · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1768224
| Field | Detail |
|---|---|
| Company | Arcturus Therapeutics Holdings Inc. (ARCT) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: ARCT
TL;DR
ARCT filed an 8-K for shareholder votes - details TBD.
AI Summary
Arcturus Therapeutics Holdings Inc. filed an 8-K on June 6, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or their outcomes, but it serves as a formal notification of these events.
Why It Matters
This filing indicates that Arcturus Therapeutics is engaging with its shareholders on important corporate matters, which could impact the company's direction and governance.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial or operational risks.
Key Players & Entities
- Arcturus Therapeutics Holdings Inc. (company) — Registrant
- June 6, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 10628 Science Center Drive, Suite 250, San Diego, California 92121 (address) — Principal executive offices
- (858) 900-2660 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of Arcturus Therapeutics' security holders?
The filing does not specify the exact matters submitted for a vote, only that such matters were presented.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 6, 2025.
What is the principal executive office address for Arcturus Therapeutics Holdings Inc.?
The principal executive offices are located at 10628 Science Center Drive, Suite 250, San Diego, California 92121.
In which state is Arcturus Therapeutics Holdings Inc. incorporated?
Arcturus Therapeutics Holdings Inc. is incorporated in Delaware.
What is the purpose of this 8-K filing for Arcturus Therapeutics?
The purpose of this 8-K filing is to report on the submission of matters to a vote of security holders.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding Arcturus Therapeutics Holdings Inc. (ARCT).